Medtronic 2009 Annual Report Download - page 2

Download and view the complete annual report

Please find page 2 of the 2009 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 106

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106

Renan Altendorff Brazil—Insulin pump to control diabetes
Chima Miyaori Japan—Microdebrider to remove tonsils causing sleep apnea
David Mangram U.S.—Intrathecal Baclofen Therapy to treat symptoms of stroke
To contribute to human welfare by the
application of biomedical engineering in
the research, design, manufacture and
sale of products that alleviate pain,
restore health and extend life.
Our Mission
About Medtronic
Medtronic is a global leader in medical technology,
redefining how technology is used in the
management of chronic disease. Our deep
understanding of human physiology yields unique
insight into a range of therapeutic areas, including
heart disease, diabetes, neurological disorders,
spinal conditions and vascular diseases. This
breadth of offerings, combined with our years of
experience, allows us to deliver therapies that are
transforming the treatment of chronic disease and
changing the lives of more than 7 million patients
worldwide each year.
Medtronic is headquartered in Minneapolis,
Minnesota; we serve patients and physicians in 120
countries through more than 38,000 employees;
and we are publicly traded on the New York Stock
Exchange under the symbol MDT.